178 related articles for article (PubMed ID: 25132000)
1. Keloids in Rubinstein-Taybi syndrome: a clinical study.
van de Kar AL; Houge G; Shaw AC; de Jong D; van Belzen MJ; Peters DJ; Hennekam RC
Br J Dermatol; 2014 Sep; 171(3):615-21. PubMed ID: 25132000
[TBL] [Abstract][Full Text] [Related]
2. [Rubinstein-Taybi syndrome with multiple keloids].
Sammartino A; Cerbella R; Lembo G; Federico A; Loffredo L
J Fr Ophtalmol; 1986; 9(11):725-9. PubMed ID: 3571836
[TBL] [Abstract][Full Text] [Related]
3. Rubinstein-Taybi syndrome with multiple flamboyant keloids.
Hendrix JD; Greer KE
Cutis; 1996 May; 57(5):346-8. PubMed ID: 8726717
[TBL] [Abstract][Full Text] [Related]
4. Rubinstein-Taybi syndrome. Cutaneous manifestations and colossal keloids.
Selmanowitz VJ; Stiller MJ
Arch Dermatol; 1981 Aug; 117(8):504-6. PubMed ID: 7259246
[No Abstract] [Full Text] [Related]
5. From Whole Gene Deletion to Point Mutations of EP300-Positive Rubinstein-Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks.
Negri G; Magini P; Milani D; Colapietro P; Rusconi D; Scarano E; Bonati MT; Priolo M; Crippa M; Mazzanti L; Wischmeijer A; Tamburrino F; Pippucci T; Finelli P; Larizza L; Gervasini C
Hum Mutat; 2016 Feb; 37(2):175-83. PubMed ID: 26486927
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of keloids and pilomatricoma in a patient with Rubinstein-Taybi syndrome.
Yagi Y; Kuwatsuka Y; Asai M; Honda M; Utani A
Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469775
[TBL] [Abstract][Full Text] [Related]
7. Benign and malignant tumors in Rubinstein-Taybi syndrome.
Boot MV; van Belzen MJ; Overbeek LI; Hijmering N; Mendeville M; Waisfisz Q; Wesseling P; Hennekam RC; de Jong D
Am J Med Genet A; 2018 Mar; 176(3):597-608. PubMed ID: 29359884
[TBL] [Abstract][Full Text] [Related]
8. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.
López M; García-Oguiza A; Armstrong J; García-Cobaleda I; García-Miñaur S; Santos-Simarro F; Seidel V; Domínguez-Garrido E
BMC Med Genet; 2018 Mar; 19(1):36. PubMed ID: 29506490
[TBL] [Abstract][Full Text] [Related]
9. Keloids and neoplasms in the Rubinstein-Taybi syndrome.
Siraganian PA; Rubinstein JH; Miller RW
Med Pediatr Oncol; 1989; 17(6):485-91. PubMed ID: 2586363
[TBL] [Abstract][Full Text] [Related]
10. A Case Report of Rubinstein-Taybi Syndrome Presenting with Extensive Keloid Formation and Review of Literature.
Kim JW; Ko JM; Lee DY; Shin JW
Ann Dermatol; 2023 May; 35(Suppl 1):S19-S24. PubMed ID: 37853858
[TBL] [Abstract][Full Text] [Related]
11. Growth charts for individuals with Rubinstein-Taybi syndrome.
Beets L; Rodríguez-Fonseca C; Hennekam RC
Am J Med Genet A; 2014 Sep; 164A(9):2300-9. PubMed ID: 24989455
[TBL] [Abstract][Full Text] [Related]
12. Rubinstein-Taybi syndrome in diverse populations.
Tekendo-Ngongang C; Owosela B; Fleischer N; Addissie YA; Malonga B; Badoe E; Gupta N; Moresco A; Huckstadt V; Ashaat EA; Hussen DF; Luk HM; Lo IFM; Hon-Yin Chung B; Fung JLF; Moretti-Ferreira D; Batista LC; Lotz-Esquivel S; Saborio-Rocafort M; Badilla-Porras R; Penon Portmann M; Jones KL; Abdul-Rahman OA; Uwineza A; Prijoles EJ; Ifeorah IK; Llamos Paneque A; Sirisena ND; Dowsett L; Lee S; Cappuccio G; Kitchin CS; Diaz-Kuan A; Thong MK; Obregon MG; Mutesa L; Dissanayake VHW; El Ruby MO; Brunetti-Pierri N; Ekure EN; Stevenson RE; Muenke M; Kruszka P
Am J Med Genet A; 2020 Dec; 182(12):2939-2950. PubMed ID: 32985117
[TBL] [Abstract][Full Text] [Related]
13. Clinical genetics of familial keloids.
Marneros AG; Norris JE; Olsen BR; Reichenberger E
Arch Dermatol; 2001 Nov; 137(11):1429-34. PubMed ID: 11708945
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome.
Bartsch O; Rasi S; Delicado A; Dyack S; Neumann LM; Seemanová E; Volleth M; Haaf T; Kalscheuer VM
Hum Genet; 2006 Sep; 120(2):179-86. PubMed ID: 16783566
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome Analysis of iPSC-Derived Neurons from Rubinstein-Taybi Patients Reveals Deficits in Neuronal Differentiation.
Calzari L; Barcella M; Alari V; Braga D; Muñoz-Viana R; Barlassina C; Finelli P; Gervasini C; Barco A; Russo S; Larizza L
Mol Neurobiol; 2020 Sep; 57(9):3685-3701. PubMed ID: 32562237
[TBL] [Abstract][Full Text] [Related]
16. Intestinal malrotation in Rubinstein-Taybi syndrome.
Stevens CA
Am J Med Genet A; 2015 Oct; 167A(10):2399-401. PubMed ID: 26097216
[TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300.
Bartholdi D; Roelfsema JH; Papadia F; Breuning MH; Niedrist D; Hennekam RC; Schinzel A; Peters DJ
J Med Genet; 2007 May; 44(5):327-33. PubMed ID: 17220215
[TBL] [Abstract][Full Text] [Related]
18. Bilateral congenital corneal keloids and anterior segment mesenchymal dysgenesis in a case of Rubinstein-Taybi syndrome.
Rao SK; Fan DS; Pang CP; Li WW; Ng JS; Good WV; Lam DS
Cornea; 2002 Jan; 21(1):126-30. PubMed ID: 11805525
[TBL] [Abstract][Full Text] [Related]
19. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.
Bartsch O; Schmidt S; Richter M; Morlot S; Seemanová E; Wiebe G; Rasi S
Hum Genet; 2005 Sep; 117(5):485-93. PubMed ID: 16021471
[TBL] [Abstract][Full Text] [Related]
20. Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.
Milani D; Manzoni FM; Pezzani L; Ajmone P; Gervasini C; Menni F; Esposito S
Ital J Pediatr; 2015 Jan; 41():4. PubMed ID: 25599811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
